Syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to bortezomib in a light chain multiple myeloma. Treatment with tolvaptan

Por Agustín Carreño, Belén Hernández, Ángel Mayoralas, Carmen Calle
Publicado em 2017-09-01